Daxor Corporation Fundamental Analysis
Daxor Corporation (DXR) shows strong financial fundamentals with a PE ratio of 5.39, profit margin of 61.05%, and ROE of 22.50%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 68.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze DXR's fundamental strength across five key dimensions:
Efficiency Score
ExcellentDXR demonstrates superior asset utilization.
Valuation Score
ExcellentDXR trades at attractive valuation levels.
Growth Score
ModerateDXR shows steady but slowing expansion.
Financial Health Score
ModerateDXR shows balanced financial health with some risks.
Profitability Score
ExcellentDXR achieves industry-leading margins.
Key Financial Metrics
Is DXR Expensive or Cheap?
P/E Ratio
DXR trades at 5.39 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, DXR's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Daxor Corporation at 1.08 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.14 times EBITDA. This is generally considered low.
How Well Does DXR Make Money?
Net Profit Margin
For every $100 in sales, Daxor Corporation keeps $61.05 as profit after all expenses.
Operating Margin
Core operations generate 61.74 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $22.50 in profit for every $100 of shareholder equity.
ROA
Daxor Corporation generates $19.93 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Daxor Corporation generates strong operating cash flow of $168.87K, reflecting robust business health.
Free Cash Flow
Daxor Corporation generates strong free cash flow of $168.87K, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.03 in free cash annually.
FCF Yield
DXR converts 0.34% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
5.39
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.003
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.08
vs 25 benchmark
P/S Ratio
Price to sales ratio
327.42
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.002
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.20
vs 25 benchmark
ROCE
Return on capital employed
0.20
vs 25 benchmark
How DXR Stacks Against Its Sector Peers
| Metric | DXR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 5.39 | 34.27 | Better (Cheaper) |
| ROE | 22.50% | 377.00% | Weak |
| Net Margin | 6105.29% | -42945.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.78 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 5.54 | Weak Liquidity |
| ROA | 19.93% | -162.00% (disorted) | Strong |
DXR outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Daxor Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation